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Abstract. Understanding variations in malaria transmission and exposure is critical to identify populations at risk
and enable better targeting of interventions. The indigenous Batwa of southwestern Uganda have a disproportionate
burden of malaria infection compared with their non-indigenous neighbors. To better understand the individual- and
community-level determinants of malaria exposure, a seroepidemiological study was conducted in 10 local council
cells in Kanungu District, Uganda, in April 2014. The Batwa had twice the odds of being seropositive to two Plasmo-
dium falciparum–specific antigens, apical membrane antigen-1 and merozoite surface protein-119, compared with
the non-indigenous Bakiga (odds ratio = 2.08, 95% confidence interval = 1.51–2.88). This trend was found
irrespective of altitude level and after controlling for cell location. Seroconversion rates in the Batwa were more than
twice those observed in the Bakiga. For the Batwa, multiple factors may be associated with higher exposure to
malaria and antibody levels relative to their non-indigenous neighbors.
Considerable heterogeneity in malaria transmission levels
and disease burden can be found within and between
populations in endemic areas, due to variations in local vector
populations, socioeconomic factors, and individual suscepti-
bility.1,2 Understanding this variation is important to enable
better deployment of interventions to reach the populations
most at risk.
Malaria transmission intensity is commonly measured
using the entomological inoculation rate (EIR; the number
of infectious bites per person per year) and/or parasite rate
(the number of infected individuals per population). However,
in low-transmission settings, these metrics lack sensitivity
due to low numbers of infected mosquitos and humans.3
Serological techniques are increasingly used in the assess-
ment of malaria transmission intensity and provide credible
estimates of transmission that correlate well with EIR.4
At an individual level, antibody responses can provide an
alternative measure against which to assess risk of exposure
to infection.5,6
This study presents the results of a seroepidemiological
study investigating exposure to malaria in the indigenous
Batwa and neighboring non-indigenous populations in Kanungu
District, located in southwestern Uganda, bordering the
Democratic Republic of Congo. The district is largely rural
and is characterized by mesoendemic malaria transmission
with intermittent epidemics of disease.7,8 Rainfall is bimodal
with peaks in April and October.
The Batwa are traditional hunter-gatherers from Uganda,
Burundi, Rwanda, and eastern Congo.9 There are approxi-
mately 6,700 Batwa individuals residing in southwestern
Uganda, comprising the easternmost population of central
Africa’s pygmy population.10 In 1992, the Batwa in Uganda
were evicted from their traditional forest homelands due to
the formation of Bwindi Impenetrable National Park.11 The
dominant non-indigenous ethnic group in the region, the
Bakiga, are traditional agriculturalists, originally migrating
from Rwanda to Uganda before the time of European colo-
nization in the early 1900s and settling in the southwestern
region of the country.12
Approval for this study was granted from the research
ethics boards of McGill University (Ref: A11-M120-13B),
the London School of Hygiene and Tropical Medicine
(Ref: 7761), the Ottawa Hospital Research Network (Ref:
20150201-01H), and the University of Guelph (Ref: 14MR002).
The study design is consistent with the Canadian Tri-Council’s
policies and requirements of the Ethical Conduct of Research
Involving Human Subjects. Informed consent was obtained
verbally from all participants and village chairpersons.
Community-based cross-sectional surveys were conducted
as described in detail elsewhere.13,14 In April 2014, 136
indigenous Batwa households and 201 non-indigenous Bakiga
households were surveyed in the 10 local councils (hereafter
referred to as “cells”) in Kanungu District, comprising all of
Kanungu’s 10 Batwa settlements and their neighboring
Bakiga villages, resulting in a total of 543 and 731 individuals,
respectively. The response rate was 94.9% and 99.4% among
the Batwa and Bakiga, respectively. Ages ranged from < 1 to
96 years (mean = 20.4 years) among the Batwa and < 1 to
87 years (mean = 22.7 years) among the Bakiga. Population
samples were comparable in age and sex, although the
Batwa population had slightly more men (44.9% versus
38.9%, χ2 = 4.26, P = 0.039) and was slightly younger (50.5%
versus 46.8% under 15 years of age, χ2 = 13.1, P = 0.011)
compared with the Bakiga. Ownership and usage of insecticide-
treated bednets were lower among Batwa individuals (33.8%
versus 47.2%, χ2 = 22.3, P < 0.001, and 21.3% versus
40.3%, χ2 = 52.5, P < 0.001, respectively). The majority
of individuals in both populations lived in houses with
iron sheet roofing: 88.8% among the Batwa and 90.0%
among the Bakiga (P = 0.49).
Malaria prevalence by CareStart™ malaria rapid diagnos-
tic tests (mRDTs) was 14.9% among the Batwa compared
with 9.26% among the Bakiga (χ2 = 33.0 P < 0.001). In
univariable regression analyses, age, ethnicity, bednet own-
ership, and household roof material were associated with
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mRDT positivity. These variables were included in a mixed-
effects logistic regression along with two cell-level factors,
elevation and normalized differential vegetation index
(NDVI). In the final model, after controlling for age and cell-
level clustering, there were no significant effects of sex,
bednet ownership, roof material, or NDVI on mRDT posi-
tivity. However, a significant altitude–ethnicity interaction
effect was found. In population-specific models, higher ele-
vation was significantly associated with lower odds of mRDT
positivity among the Bakiga (odds ratio [OR] = 0.19, 95%
confidence interval [CI] = 0.11–0.35, P < 0.001 at elevations
1,301–1,500 m; OR = 0.11, 95% CI = 0.04–0.33, P < 0.001 at
elevations > 1,500 m). In contrast, among the Batwa, the
effect was less clear, with no altitude effect at 1,301–1,500 m
(OR = 1.16, 95% CI = 0.73–1.82, P = 0.534) and lower odds
of mRDT positivity at elevations > 1,500 m (OR = 0.39, 95%
CI = 0.20–0.71, P = 0.003) (Figure 1).
Antibodies were eluted from filter paper blood spots
and assayed by enzyme-linked immunosorbent assay, as pre-
viously described.5 All Batwa (N = 543) and Bakiga (N = 731)
samples were tested for the presence of human antibodies
(IgG) against merozoite surface protein-119 (MSP-119) and api-
cal membrane antigen-1 (AMA-1) of Plasmodium falciparum.
To define seropositive individuals, the optical density data
were fitted using maximum likelihood methods to establish
seronegative and seropositive Gaussian distributions. For each
antigen, the cutoff was set as the mean titer of the seronega-
tive distribution plus three standard deviations.15 Overall,
seroprevalence of antibodies to AMA-1 was higher than
MSP-119 in both study populations. Individuals with current
FIGURE 1. Prevalence of malaria infection measured by malaria rapid diagnostic test (mRDT) and Plasmodium falciparum seroprevalence
among the Batwa (solid line) and Bakiga (dashed line) living at different altitudes in Kanungu District, Uganda, in 2014.
FIGURE 2. Logarithmic antibody titers by age group in the Batwa (N = 543) and Bakiga (N = 731) in Kanungu District, Uganda, in 2014 for
(A) anti-AMA-1 and (B) anti-MSP-119. An asterisk indicates that significant differences exist between populations within the same age group.
Sample size by age group for Batwa: < 5 years (N = 125), 6–15 years (N = 146), 16–25 years (N = 87), 26–40 years (N = 77), > 40 years
(N = 104), and Bakiga: < 5 years (N = 157), 6–15 years (N = 174), 15–25 years (N = 94), 26–40 years (N = 156), > 40 years (N = 126). AMA-1 =
apical membrane antigen-1; MSP-119 = merozoite surface protein-119.
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P. falciparum infection measured by mRDT were significant
more likely than mRDT-negative individuals to be seroposi-
tive (76.0% versus 50.5%, OR = 3.11, 95% CI = 2.02–4.78,
P < 0.001) and had higher antibody responses to both
MSP-119 and AMA-1 (F = 13.2, P < 0.001 and F = 6.60, P =
0.01, respectively).
In univariable regression analyses, age, ethnicity, current
infection status measured by mRDT, and bednet ownership
FIGURE 3. Age–seroprevalence curves for anti–Plasmodium falciparum antibody responses corresponding to (A) Batwa AMA-1 and
(B) Bakiga AMA-1 seropositive individuals; (C) Batwa MSP-119 and (D) Bakiga MSP-119 individuals; (E) all Batwa and (F) all Bakiga seropositive
individuals in Kanungu District, Uganda, in 2014. Triangles represent observed data, and the dotted blue line represents the upper and lower
95% confidence intervals for the predicted seroprevalence curve. Seroconversion rates: (A) λ = 0.057, (B) λ = 0.031, (C) λ = 0.053, (D) λ = 0.024,
(E) λ = 0.088, (F) λ = 0.044. AMA-1 = apical membrane antigen-1; MSP-119 = merozoite surface protein-119.
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were associated with seropositivity. In a mixed-effects logistic
regression, after adjusting for age, infection status, elevation,
and clustering by cell, the Batwa had a 2-fold higher odds of
being seropositive compared with the Bakiga (OR = 2.08,
95% CI = 1.51–2.88). The mixed-effects model showed no
significant effect of sex, bednet ownership or NDVI, and no
significant altitude–ethnicity interaction. Increasing elevation
was significantly associated with reduced odds of seropreva-
lence among both the Batwa and Bakiga (OR = 0.24, 95%
CI = 0.10–0.57, P = 0.001 at elevations 1,301–1,500 m; OR =
0.11, 95% CI = 0.04–0.33, P < 0.001 at elevations > 1,500 m).
The Batwa had consistently higher seroprevalence than
Bakiga living at the similar elevations (Figure 1).
Mean MSP-119 and AMA-1 specific antibody titers were
significantly lower in the Bakiga compared with the Batwa
(F = 28.37, P < 0.001 and F = 5.76, P = 0.016, respectively).
A comparison of antibody titers by age group is shown in
Figure 2. Reverse cumulative distribution curves of untrans-
formed AMA-1 and MSP-119 antibody titers were generated
to allow for visual inspection of variability and central tenden-
cies of antibody data.16 These demonstrated a higher propor-
tion of individuals with elevated antibody titers among the
Batwa for both antigens.
A simple reversible catalytic model was fitted to the sero-
prevalence data using maximum likelihood methods.4 The
resulting age–seroprevalence curves illustrate the cumulative
rate of exposure to P. falciparum antigens in each population
(Figure 3). Seroconversion rates for AMA-1 and MSP-119 in
the Batwa were more than 2-fold higher than those in the
Bakiga (overall λ = 0.088, 95% CI = 0.071–0.109, versus λ =
0.044, 95% CI = 0.035–0.054).
These data strongly suggest that the indigenous Batwa
of Kanungu, Uganda, are a population at heightened risk
of malaria exposure and infection. In comparison to the
neighboring non-indigenous Bakiga population, after account-
ing for age, the Batwa had twice the odds of seropositivity
and double the rate of seroconversion based on malaria-
specific antibodies.
Differences in elevation partly explain the between-cell
differences in seroprevalence, with a trend towards lower
seroprevalence at higher altitudes. This suggests that higher
seroprevalence reflects increased exposure to infected vec-
tors at lower altitudes. However, higher seroprevalence of
antibodies to AMA-1 and MSP-119 antigens was observed
among the Batwa relative to the Bakiga irrespective of alti-
tude level, indicating that other population-specific deter-
minants for malaria exposure may exist, and that certain
factors may increase the Batwa’s vulnerability to malaria
exposure relative to their Bakiga neighbors. In addition to
higher seroprevalence among the Batwa, the magnitude of
antibody titers indicates that the Batwa are producing a sig-
nificantly higher immune response to both MSP-119 and
AMA-1 in relation to their non-indigenous neighbors. This
could be explained by a lack of prior exposure to malaria
parasites due to their previous habitation within the forest,
resulting in the Batwa being immunologically naive to
Plasmodium infection. Alternatively, genetic differences may
play a role in the Batwa’s production of such a strong immu-
nological response to malarial infection, similar to the Fulani
tribe of Burkina Faso,17–19 though the higher prevalence of
infections among the Batwa suggests that this explanation,
at least as a protective effect, is less likely.
This study has several limitations. The survey design did
not permit georeferencing individual household locations;
therefore, no spatial analysis or household-level entomologi-
cal assessment was possible to investigate patterns of
transmission within individual cells. Further immunological
and genetic studies would be needed to investigate whether
the Batwa’s antibody response confers protective immunity
or is genetically mediated; however, this was beyond the
scope of the present study.
For the Batwa, the causes of higher malaria exposure and
antibody levels are likely multifactorial. Further characteriza-
tion of malaria transmission in Batwa and Bakiga communities
through spatial analysis and entomological evaluation of malaria
vectors, along with cohort studies on coincidence of infection
using a more sensitive malaria diagnostic such as polymerase
chain reaction and antibody responses to a broader suite of
antigens, would help to clarify population heterogeneities.
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